4 Results for "

Leelamine

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Leelamine" in MCE Product Catalog:

Cat. No.: HY-W005629
CAS No.: 1446-61-3
Leelamine is an orally active pyruvate dehydrogenase kinase (PDK) inhibitor with an IC50 value of 9.5 μM, showing a blood glucose lowering effect in the diabetic mouse. Leelamine is also a weak agonist of cannabinoid receptors CB1 and CB2. Leelamine decreases mitotic activity, prostate-specific antigen expression and induces Apoptosis to cell death in cancer cells .
loading...
    loading...
Cat. No.: HY-110028
CAS No.: 16496-99-4
Purity:  99.06%
Leelamine hydrochloride is an orally active weakly basic amine that inhibits NPC1 and the androgen receptor AR-V7, and acts as a cannabinoid receptor agonist. Leelamine hydrochloride also functions as a lysosome affinity agent that blocks endocytosis, disrupts autophagic flux and cholesterol transport, thereby altering the RTK-AKT/STAT/MAPK signaling cascade. Leelamine hydrochloride induces cancer cell death and autophagosome accumulation, and can be used in research related to melanoma, castration-resistant prostate cancer and breast cancer .
loading...
    loading...
Cat. No.: HY-173581
CAS No.: 2841710-23-2
Target:  

PDHK

Research Areas:  

Cancer

Arachidonic acid leelamide, a Leelamine (HY-W005629) analog, is a pyruvate dehydrogenase kinase (PDK) inhibitor. Arachidonic acid leelamide can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-176008
CAS No.: 2095306-47-9
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology

Lauric acid leelamide is the lauric acid (C-12) amide analog of Leelamine (HY-W005629). Leelamine exhibits inhibitory activity against pyruvate dehydrogenase kinase (PDHK) with an IC50 value of 9.5 µM. Leelamine derivatives possess anti-inflammatory effects and can inhibit phospholipase A2 activity from various sources .
loading...
    loading...